FDA Postpones Plan B OTC Switch Decision Until May
This article was originally published in The Pink Sheet Daily
Executive Summary
Ninety-day extension of the user fee deadline will allow the agency to review additional data on adolescent use of the emergency contraceptive, Barr says.